SCHEMBL6648237

SCHEMBL6648237

N=C(N)CCCC1CC(c2ccccc2)=CCN1

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
F2 P00734 5/20 0.39
SIGMAR1 Q99720 1/20 0.34
HTR2C P28335 1/20 0.33
HTR6 P50406 1/20 0.30
PRSS1 P07477 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6368137 0.97 LMNA (0.39) LMNAF2SIGMAR1HTR2C
SCHEMBL6676171 0.87 F2 (0.32) F2
SCHEMBL6648539 0.87 SIGMAR1 (0.37) F2SIGMAR1HTR2C
SCHEMBL9868832 0.81 SIGMAR1 (0.39) F2SIGMAR1HTR2C
SCHEMBL6649065 0.81 IDO1 (0.32)
Hydrochloric Acid SCHEMBL6586236 0.79 HTR2C (0.41) F2SIGMAR1HTR2C
SCHEMBL7014444 0.77 PDCD1 (0.42) LMNA
SCHEMBL5401265 0.76 SIGMAR1 (0.34) F2SIGMAR1HTR2C
SCHEMBL6648602 0.75 SIGMAR1 (0.36) F2SIGMAR1HTR2C
SCHEMBL6648243 0.75 SIGMAR1 (0.36) F2SIGMAR1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1469854-A1 CONDENSED HETEROCYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-10-27 EP disclosed
EP-1355888-A1 QUINAZOLINONE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-10-29 EP disclosed
WO-2003063874-A1 CONDENSED HETEROCYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-08-07 WO disclosed
WO-2002048117-A1 QUINAZOLINONE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-20 WO disclosed